期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Malignant meningioma of the cerebellopontine angle in a 2-year-old girl:a case report and literature review 被引量:1
1
作者 Ming-Chao Fan Xin Zhang +4 位作者 Qiao-Ling Wang Lei Cheng Cai-Yun Dai Dan Yu Peng Sun 《Chinese Journal of Cancer》 SCIE CAS CSCD 2013年第7期415-417,共3页
Meningioma is a common intracranial tumor in adults.Pediatric cases account for approximately 1.5% of all intracranial meningiomas,and very few cases show malignant histological features.Primary pediatric malignant me... Meningioma is a common intracranial tumor in adults.Pediatric cases account for approximately 1.5% of all intracranial meningiomas,and very few cases show malignant histological features.Primary pediatric malignant meningioma in the cerebellopontine angle is extremely uncommon.Herein,we report a 2-yearold girl with malignant meningioma in the cerebellopontine angle.The clinical features,diagnosis,and treatment protocol are discussed. 展开更多
关键词 病例报告 脑膜瘤 恶性 文献综述 女孩 脑桥 组织学特征 临床特点
下载PDF
Antithrombotic therapy in patients with COVID-19:indications,pharmacotherapy and controversy
2
作者 David Wang Christopher Leo +3 位作者 Liping Liu Li Huang Lisa Huang Yun Lu 《Stroke & Vascular Neurology》 SCIE CSCD 2023年第4期263-265,共3页
Hypercoagulability associated with COVID-19 infection increases risks for either venous or arterial thrombotic events(ATEs)or both.1 For hospitalised patients with COVID-19,the incidence of venous thromboembolism(VTE)... Hypercoagulability associated with COVID-19 infection increases risks for either venous or arterial thrombotic events(ATEs)or both.1 For hospitalised patients with COVID-19,the incidence of venous thromboembolism(VTE)was 4.5%2;the rate among patients with crit-ical illness was 27.9%as compared with those not critically ill(7.1%).The exact mechanism of COVID-19-related thrombotic events is unclear.However,it may partially be related to Virchow triad:alternation of blood flow(stasis),vascular endothelial injury by SARS-CoV 2 virus and alteration of the constituents of the blood including inherited or acquired hypercoagulable state.Therefore,it is a challenge to evaluate the thromboembolic risk,select an appropriate antithrombotic agent and decide on the doses and duration of therapy in these patients.Several international and American societies have published clinical guidelines that reviewed evaluation of coagulation abnormalities in patients with COVID-19.3-6 To balance the risk of bleeding and preventing or treating thromboembolic events,a simplified practical summarisation is needed. 展开更多
关键词 PATIENTS THROMBOTIC doses
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部